Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 2 subunit 2 beta pseudogene 7 (EIF2S2P7) is a **pseudogene** in the human genome, annotated in sources including Ensembl and GeneCards[5][7][9][11]. It is related by sequence to EIF2S2, which encodes the functional beta subunit of translation initiation factor 2, a key component in the early steps of protein synthesis. However, as a pseudogene, EIF2S2P7 does not produce a functional protein and is not believed to play a role as a receptor, enzyme, or therapeutic target. No alternate names, molecular function, or involvement in disease or drug response has been reported for this pseudogene. The functional gene EIF2S2 is involved in translation initiation and does have associations with disease and biological functioning, but EIF2S2P7 itself does not. Therefore, this entry is best considered **not a true therapeutic target**, and inclusion in a drug-target list would be incorrect[11].
None (not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 2 subunit 2 beta pseudogene 7 (EIF2S2P7).